Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000085
Filing Date
2025-03-20
Accepted
2025-03-20 17:29:53
Documents
87
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3667685
2 ex19-1.htm EX-19.1 189146
3 ex21-1.htm EX-21.1 5907
4 ex23-1.htm EX-23.1 4579
5 ex31-1.htm EX-31.1 15640
6 ex31-2.htm EX-31.2 14687
7 ex32-1.htm EX-32.1 7768
8 ex32-2.htm EX-32.2 5075
9 form10-k_001.jpg GRAPHIC 6026
10 form10-k_002.jpg GRAPHIC 4365
11 audit_001.jpg GRAPHIC 5814
  Complete submission text file 0001641172-25-000085.txt   12998954

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE mgrx-20241231.xsd EX-101.SCH 58793
13 XBRL CALCULATION FILE mgrx-20241231_cal.xml EX-101.CAL 68643
14 XBRL DEFINITION FILE mgrx-20241231_def.xml EX-101.DEF 321833
15 XBRL LABEL FILE mgrx-20241231_lab.xml EX-101.LAB 566493
16 XBRL PRESENTATION FILE mgrx-20241231_pre.xml EX-101.PRE 457334
89 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1497506
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41615 | Film No.: 25757871
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)